Getting doctors to like biosimilars

Save

Approving biosimilars is one thing; getting doctors to prescribe them is quite another. Usage of biosimilars is increasing in the EU, at least for some product classes, but it remains patchy, and while payers will welcome the cost savings biosimilars may…